Dr. Maxwell Harris Stroebel, MD

Dr. Stroebel practices at Prisma Health Hillcrest Hospital in Simpsonville, South Carolina, part of Prisma Health.

Dr. Stroebel's NPI, 1710479852, was assigned on June 5, 2018. Dr. Stroebel graduated from University of South Carolina School of Medicine in 2018. Dr. Stroebel holds South Carolina license 52738.

Dr. Stroebel's primary practice is Prisma Health Hillcrest Hospital, at 741 South East Main Street, Simpsonville, SC 29681 in Greenville County. The practice phone is (864) 454-6100. Dr. Stroebel also practices at Hillcrest Hospital, 729 SE Main St, Simpsonville, SC 29681.

Dr. Stroebel's primary practice is Prisma Health Hillcrest Hospital in Simpsonville, South Carolina, part of Prisma Health. Dr. Stroebel is also affiliated with Prisma Health Greenville Memorial Hospital. The medical group on file is Prisma Health Medical Group. Dmand AI also links Dr. Stroebel to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stroebel practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Stroebel's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Stroebel is licensed in South Carolina.

CMS data shows 1,276 Medicare services from Dr. Stroebel across 26 procedure codes in 2024, for 1,342 Medicare patients. Medicare paid $41,121 for them.

CMS counts 1,342 Medicare patients who saw Dr. Stroebel in 2024. The largest group is 65 to 74, with 551 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stroebel's median patient age at 56, with 62% women.

In 2024, Dr. Stroebel wrote 21 Medicare Part D claims for 13 patients. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $48 in total drug cost. In 2019, CMS named 100 claims across 5 drugs.

Dr. Stroebel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Stroebel, published from 2016 to 2022. Dr. Stroebel's most frequent co-authors are Barry C. Gibney, DO and Ashley Hannah Parinella, MD.

CMS Open Payments shows 24 general payments to Dr. Stroebel from 8 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 62% of the total. Penumbra, Inc. paid the most, $2,071.

Dr. Stroebel graduated from University of South Carolina School of Medicine in 2018.